The 2020 WHO classification of tumors of bone: an updated review
JH Choi, JY Ro - Advances in anatomic pathology, 2021 - journals.lww.com
Bone tumors are a rare and heterogeneous group of neoplasms that occur in the bone. The
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …
diversity and considerable morphologic overlap of bone tumors with other mesenchymal …
Chondrosarcoma: a clinical review
A Gazendam, S Popovic, N Parasu… - Journal of Clinical …, 2023 - mdpi.com
Chondrosarcomas are a diverse group of malignant cartilaginous matrix-producing
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
neoplasms. Conventional chondrosarcomas are a continuum of disease based on the …
Chordoma: a review and differential diagnosis
V Ulici, J Hart - Archives of Pathology & Laboratory …, 2022 - meridian.allenpress.com
Context.—Chordomas are uncommon malignant neoplasms with notochordal differentiation
encountered by neuropathologists, bone/soft tissue pathologists, and general surgical …
encountered by neuropathologists, bone/soft tissue pathologists, and general surgical …
MRI radiomics-based machine learning classification of atypical cartilaginous tumour and grade II chondrosarcoma of long bones
S Gitto, R Cuocolo, K van Langevelde… - …, 2022 - thelancet.com
Background Atypical cartilaginous tumour (ACT) and grade II chondrosarcoma (CS2) of long
bones are respectively managed with watchful waiting or curettage and wide resection …
bones are respectively managed with watchful waiting or curettage and wide resection …
Chondrosarcoma-from molecular pathology to novel therapies
AE Zając, S Kopeć, B Szostakowski, MJ Spałek… - Cancers, 2021 - mdpi.com
Simple Summary Chondrosarcoma (CHS) belongs to a broad group of sarcomas and is the
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
second most frequent malignant bone tumor. Due to its resistance to chemo-and …
CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas
S Gitto, R Cuocolo, A Annovazzi, V Anelli… - …, 2021 - thelancet.com
Background Clinical management ranges from surveillance or curettage to wide resection
for atypical to higher-grade cartilaginous tumours, respectively. Our aim was to investigate …
for atypical to higher-grade cartilaginous tumours, respectively. Our aim was to investigate …
Surgical treatment of bone sarcoma
F Bläsius, H Delbrück, F Hildebrand, UK Hofmann - Cancers, 2022 - mdpi.com
Simple Summary Even today, a malignant bone tumor is still a threatening condition for the
patient. Such tumors are difficult to treat and they require an interdisciplinary approach to …
patient. Such tumors are difficult to treat and they require an interdisciplinary approach to …
MRI radiomics-based machine-learning classification of bone chondrosarcoma
S Gitto, R Cuocolo, D Albano, V Chianca… - European Journal of …, 2020 - Elsevier
Purpose To evaluate the diagnostic performance of machine learning for discrimination
between low-grade and high-grade cartilaginous bone tumors based on radiomic …
between low-grade and high-grade cartilaginous bone tumors based on radiomic …
Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta‐analysis
Introduction IDH1/2 mutations are prevalent in cartilaginous tumors including
chondrosarcoma. This meta‐analysis using individual patient data (IPD) aimed to …
chondrosarcoma. This meta‐analysis using individual patient data (IPD) aimed to …
Biology and management of high-grade chondrosarcoma: An update on targets and treatment options
C Tlemsani, F Larousserie, S De Percin… - International journal of …, 2023 - mdpi.com
This review provides an overview of histopathology, clinical presentation, molecular
pathways, and potential new systemic treatments of high-grade chondrosarcomas (CS) …
pathways, and potential new systemic treatments of high-grade chondrosarcomas (CS) …